• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移至胸膜的恶性肿瘤。

Malignancies metastatic to the pleura.

作者信息

Matthay R A, Coppage L, Shaw C, Filderman A E

机构信息

Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.

出版信息

Invest Radiol. 1990 May;25(5):601-19. doi: 10.1097/00004424-199005000-00025.

DOI:10.1097/00004424-199005000-00025
PMID:2188932
Abstract

In patients over 50 years of age, neoplasms of the pleura are probably the second most common cause of a pleural effusion after congestive heart failure. Lung cancer, breast cancer, lymphoma, ovarian carcinoma, and stomach cancer are the leading causes of malignant pleural disease, and adenocarcinoma is the most common cell type. This review discusses in detail the etiology and incidence, pathogenesis, clinical manifestations, diagnosis, prognosis, and treatment of neoplasms that involve the pleura with special reference to malignant and paramalignant pleural effusions.

摘要

在50岁以上的患者中,胸膜肿瘤可能是继充血性心力衰竭之后导致胸腔积液的第二大常见病因。肺癌、乳腺癌、淋巴瘤、卵巢癌和胃癌是恶性胸膜疾病的主要病因,腺癌是最常见的细胞类型。本综述详细讨论了累及胸膜的肿瘤的病因和发病率、发病机制、临床表现、诊断、预后及治疗,特别提及了恶性和准恶性胸腔积液。

相似文献

1
Malignancies metastatic to the pleura.转移至胸膜的恶性肿瘤。
Invest Radiol. 1990 May;25(5):601-19. doi: 10.1097/00004424-199005000-00025.
2
Malignant pleural effusions.恶性胸腔积液
Clin Chest Med. 1985 Mar;6(1):113-25.
3
Pulmonary and pleural manifestations of extrathoracic malignancies.
Clin Chest Med. 1989 Dec;10(4):747-807.
4
Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.通过结合临床、放射学和胸水分析参数预测恶性及准恶性胸腔积液
Lung. 2017 Oct;195(5):653-660. doi: 10.1007/s00408-017-0032-3. Epub 2017 Jun 27.
5
Cytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patients.
Diagn Cytopathol. 1987 Mar;3(1):8-12. doi: 10.1002/dc.2840030103.
6
Malignant pleural effusions.恶性胸腔积液
Postgrad Med. 1986 Oct;80(5):201-9. doi: 10.1080/00325481.1986.11699569.
7
[A case of pleural effusion secondary to breast carcinoma responding to treatment based upon thoracoscopic findings].[一例继发于乳腺癌的胸腔积液经基于胸腔镜检查结果的治疗后有效]
Gan To Kagaku Ryoho. 1990 Apr;17(4 Pt 1):685-8.
8
The pathology of benign and malignant pleural disease.良性和恶性胸膜疾病的病理学
Chest Surg Clin N Am. 1994 Aug;4(3):405-30.
9
The etiology of pleural effusions in an area with high incidence of tuberculosis.结核病高发地区胸腔积液的病因
Chest. 1996 Jan;109(1):158-62. doi: 10.1378/chest.109.1.158.
10
Pleural metastatic tumours and effusions. Frequency and pathogenic mechanisms in a post-mortem series.
Eur Respir J. 1989 Apr;2(4):366-9.

引用本文的文献

1
Talc pleurodesis in malignant pleural effusion: a systematic review and meta-analysis.滑石粉胸膜固定术治疗恶性胸腔积液:系统评价和荟萃分析。
Gen Thorac Cardiovasc Surg. 2021 May;69(5):832-842. doi: 10.1007/s11748-020-01549-2. Epub 2020 Nov 22.
2
84-year-old man with respiratory distress and abdominal distention.84岁男性,伴有呼吸窘迫和腹胀。
Mayo Clin Proc. 2011 Feb;86(2):e10-3. doi: 10.4065/mcp.2010.0239.
3
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer.CSPG4 蛋白作为三阴性乳腺癌抗体免疫治疗的新靶点。
J Natl Cancer Inst. 2010 Oct 6;102(19):1496-512. doi: 10.1093/jnci/djq343. Epub 2010 Sep 17.
4
Video-assisted thoracic surgery--the past, present status and the future.电视辅助胸腔镜手术——过去、现状与未来
J Zhejiang Univ Sci B. 2006 Feb;7(2):118-28. doi: 10.1631/jzus.2006.B0118.
5
Primary thoracoscopic evaluation of pleural effusion with local anesthesia: an alternative approach.局部麻醉下胸腔镜对胸腔积液的初步评估:一种替代方法。
JSLS. 2002 Apr-Jun;6(2):143-7.
6
Carcinoembryonic antigen, tissue polypeptide antigen and neuron-specific enolase pleural levels used to classify small-cell and non-small-cell lung cancer patients by discriminant analysis.癌胚抗原、组织多肽抗原和神经元特异性烯醇化酶的胸膜水平用于通过判别分析对小细胞肺癌和非小细胞肺癌患者进行分类。
J Cancer Res Clin Oncol. 1996;122(8):499-503. doi: 10.1007/BF01187163.